InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.185 0.005 (2.63%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$111 Final Director's Interest Notice - MD 5 Nov 2026 4:34PM $0.210 $0.185 fallen by 11.90%
$111 Dimerix Quarterly Activities Report and Appendix 4C 29 Oct 2026 8:31AM $0.205 $0.185 fallen by 9.76%
$111 New Data Supports Biological Rationale for DMX-200 in FSGS 23 Oct 2026 9:27AM $0.205 $0.185 fallen by 9.76%
$111 2026 AGM Notice of Meeting, Letter of Access and Proxy Form 22 Oct 2026 8:44AM $0.210 $0.185 fallen by 11.90%
$111 Dimerix Announces Board Chair Transition 19 Oct 2026 8:30AM $0.220 $0.185 fallen by 15.91%
$111 DMX-200 First 100 Patients Complete Phase 3 Trial Treatment 16 Oct 2026 8:52AM $0.210 $0.185 fallen by 11.90%
$111 Dimerix at Canaccord Drug & Device and Ignite Conferences 12 Oct 2026 8:32AM $0.220 $0.185 fallen by 15.91%
$111 First Patient Reaches Four Years in DMX-200 Clinical Program 5 Oct 2026 8:56AM $0.225 $0.185 fallen by 17.78%
$111 Notification regarding unquoted securities - DXB 28 Sep 2026 2:34PM $0.228 $0.185 fallen by 18.68%
$111 Notification of 2026 Annual General Meeting Date 25 Sep 2026 2:42PM $0.230 $0.185 fallen by 19.57%
$111 Dimerix Presents at ASX SMIDcaps Conference 2026 23 Sep 2026 8:44AM $0.240 $0.185 fallen by 22.92%
$111 Dimerix Draws Down A$17M Under Non-Dilutive Funding Facility 23 Sep 2026 8:36AM $0.240 $0.185 fallen by 22.92%
$111 Waiver of Listing Rule 10.1 Granted 22 Sep 2026 3:46PM $0.240 $0.185 fallen by 22.92%
$111 Dimerix Presents at E&P Healthcare Conference 2026 16 Sep 2026 8:31AM $0.235 $0.185 fallen by 21.28%
$111 Dimerix DMX-652 Granted Mexican Composition of Matter Patent 14 Sep 2026 8:39AM $0.250 $0.185 fallen by 26%
$111 Dimerix Investor Presentation 7 Sep 2026 8:51AM $0.285 $0.185 fallen by 35.09%
$111 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $0.285 $0.185 fallen by 35.09%
$111 Dimerix Secures A$34 Million Non-Dilutive Funding Facility 4 Sep 2026 9:17AM $0.290 $0.185 fallen by 36.21%
$111 Trading Halt 2 Sep 2026 8:43AM $0.290 $0.185 fallen by 36.21%
$111 Appendix 4G and Corporate Governance Statement 27 Aug 2026 8:56AM $0.290 $0.185 fallen by 36.21%
$111 Appendix 4E and 2026 Annual Report 27 Aug 2026 8:56AM $0.290 $0.185 fallen by 36.21%
$111 Dimerix Receives US$10M Upfront Payment from Everest 20 Aug 2026 9:13AM $0.295 $0.185 fallen by 37.29%
$111 Dimerix Assumes Sponsorship of US IND for New Asset DMX-652 17 Aug 2026 8:38AM $0.295 $0.185 fallen by 37.29%
$111 Dimerix Presents at Bioshares Summit 2026 6 Aug 2026 8:17AM $0.290 $0.185 fallen by 36.21%
$111 Dimerix Quarterly Activities Report and Appendix 4C 30 Jul 2026 8:49AM $0.240 $0.185 fallen by 22.92%

1 - 25 of 746 results

Page 1 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.